Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Statistics
Share Statistics
Benitec Biopharma has 25.6M shares outstanding. The number of shares has increased by 172.16% in one year.
| 25.6M |
| 172.16% |
| 9.81% |
| 86.06% |
| n/a |
| 1,546 |
| 3.18% |
Short Selling Information
The latest short interest is 439.2K, so 1.72% of the outstanding shares have been sold short.
| 439.2K |
| 1.72% |
| 3.21% |
| 11.85 |
Valuation Ratios
The PE ratio is -3.43 and the forward PE ratio is -6.21. Benitec Biopharma's PEG ratio is 0.04.
| -3.43 |
| -6.21 |
| 344.9 |
| 2.7 |
| 1.58 |
| -3.8 |
| 0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Benitec Biopharma.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 10.49, with a Debt / Equity ratio of 0.01.
| 10.49 |
| 10.49 |
| 0.01 |
| -0.01 |
| -0.01 |
| -24.88 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $13,500 |
| $-1,359,437.5 |
| 16 |
| 0 |
| n/a |
Taxes
| -619K |
| 2.77% |
Stock Price Statistics
The stock price has increased by 107.49% in the last 52 weeks. The beta is 0.44, so Benitec Biopharma's price volatility has been higher than the market average.
| 0.44 |
| 107.49% |
| 13.71 |
| 11.57 |
| 57.73 |
| 48,688 |
Income Statement
In the last 12 months, Benitec Biopharma had revenue of 216K and earned -21.75M in profits. Earnings per share was -2.68.
| 216K |
| 108K |
| -22.49M |
| -21.75M |
| -22.49M |
| -21.75M |
| -2.68 |
Balance Sheet
The company has 50.87M in cash and 284K in debt, giving a net cash position of 50.58M.
| 50.87M |
| 284K |
| 50.58M |
| -190.26M |
| 105.21M |
| 96.98M |
Cash Flow
In the last 12 months, operating cash flow was -19.4M and capital expenditures -179K, giving a free cash flow of -19.58M.
| -19.4M |
| -179K |
| -19.58M |
| -1.91 |
Margins
Gross margin is 50%, with operating and profit margins of -10412.04% and -10069.91%.
| 50% |
| -10412.04% |
| -10356.48% |
| -10069.91% |
| -10412.04% |
| -10412.04% |
| -9065.74% |
Dividends & Yields
BNTC does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for BNTC is $24, which is 54.6% higher than the current price. The consensus rating is "Buy".
| $24 |
| 54.6% |
| Buy |
| 8 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Jul 26, 2023. It was a backward split with a ratio of 1:17.
| Jul 26, 2023 |
| backward |
| 1:17 |
Scores
| 29.79 |
| 2 |